Forte Biosciences, Inc. (FBRX)
NASDAQ · Healthcare
Forte Biosciences, Inc. Long Term Debt 2016–2019
Forte Biosciences, Inc. annual long term debt history from 2016 to 2018. Long term debt refers to financial obligations that are due more than one year in the future.
- Forte Biosciences, Inc. long term debt as of December 31, 2018: 26.2M, a 622.79% increase year-over-year.
- Forte Biosciences, Inc. long term debt for 2018 were 26.2M, a 622.79% increase from 2017.
- Forte Biosciences, Inc. long term debt for 2017 were 3.6M, a 64.60% decrease from 2016.
- Forte Biosciences, Inc. long term debt for 2016 were 10.2M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Forte Biosciences, Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2018 | $26 |
| 2017 | $4 |
| 2016 | $10 |
Forte Biosciences, Inc. Long Term Debt — FAQ
Forte Biosciences, Inc. (FBRX) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FBRX's long term debt history?
The chart and table above show Forte Biosciences, Inc.'s long term debt by year and by quarter, including the growth rate.